Identification of the Anti-ischemia-reperfusion Injury Effect of Baicalein from Scutellaria baicalensis Georgi in Liver Transplantation
Authors:
- 1 September 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 32 (30) , 6603-6621
Abstract
Background: The complex etiology of Ischemia-Reperfusion Injury (IRI) induced by liver transplantation (LT) and the “one-target-focused” method limit the development of effective therapeutic interventions. We aimed to reveal the specific active ingredients and mechanisms involved in the Chinese herb Scutellaria baicalensis Georgi (SBG) in alleviating IRI in LT. Methods: The active ingredients and potential macromolecular targets of SBG were screened through related databases. The differentially expressed genes of LT were obtained from GSE151648. The protein-protein interaction network was constructed by the STRING database, and Cytoscape 3.7.1 was used to construct a compound-target-disease network. GO and KEGG enrichment analyses were performed on the DAVID database. Finally, the main active components of SBG and the corresponding mechanisms were verified in a donation after circulatory death (DCD) rat LT model. Results: Thirty-two active ingredients of SBG and their targets were identified, and a total of 38 intersection targets were obtained. GO function and KEGG pathway enrichment analyses demonstrated that the plasma membrane and its components play an important role. Molecular docking showed baicalein, the core component of SBG, had a strong binding ability to all hub targets. Next, in DCD rats, baicalein was proven to improve liver function, alleviate pathological injury and apoptosis, and increase the survival rate. Baicalein also significantly affected the expression of 7 hub genes. Furthermore, baicalein could inhibit ferroptosis by inhibiting phospholipid peroxidation. Conclusion: Baicalein, the main component of SBG, could alleviate IRI, affect the expression of hub genes, and inhibit ferroptosis in LT.Keywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (cstc2020jcyj-msxmX0791)
- China Postdoctoral Science Foundation (2023MD744151)
- Science and Technology research project of the Sichuan Administration of Traditional Chinese Medicine (2023MS322)
This publication has 76 references indexed in Scilit:
- Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1/P53/SLC7A11 pathwayPhytotherapy Research, 2022
- The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive reviewBiomedicine & Pharmacotherapy, 2021
- Disulfide High‐Mobility Group Box 1 Drives Ischemia‐Reperfusion Injury in Human Liver TransplantationHepatology, 2020
- ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesisJournal of Leukocyte Biology, 2020
- Interaction of Hsp90AA1 with phospholipids stabilizes membranes under stress conditionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2019
- Liver Transplantation Today: Where We Are Now and Where We Are GoingLiver Transplantation, 2018
- Bioactive flavonoids in medicinal plants: Structure, activity and biological fateAsian Journal of Pharmaceutical Sciences, 2018
- Safety Surveillance of Traditional Chinese Medicine: Current and FutureDrug Safety, 2015
- Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liverLiver Transplantation, 2009
- The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injuryBasic Research in Cardiology, 2009